Research Articles
Cracking the Code of Difficult-to-Treat Rheumatoid Arthritis: When Standard Treatments Aren't Enough
Understanding difficult-to-treat rheumatoid arthritis (D2T RA), its diagnostic criteria, treatment strategies, and future research directions based on EULAR systematic review.
How Rheumatoid Arthritis Treatment Transformed in Just Five Years
Explore the remarkable transformation in rheumatoid arthritis treatment approaches between 2014-2020, based on the STRATEGE studies showing evolving patient profiles and treatment strategies.
The Diagnostic Puzzle of Difficult-to-Treat Rheumatoid Arthritis
Exploring the diagnostic challenges and management approaches for difficult-to-treat rheumatoid arthritis (D2T RA) based on systematic literature review.
Mapping a Decade of Rheumatoid Arthritis Research (2011-2020)
Explore the key research trends, major breakthroughs, and future directions in rheumatoid arthritis science through a comprehensive bibliometric analysis of 17,037 publications from 2011 to 2020.
The Great Arthritis Debate: Can Modern Biologics Outsmart Joint Damage?
Exploring whether biologic DMARDs offer superior protection against joint damage progression compared to synthetic antirheumatic drugs in rheumatoid arthritis patients.
The Hidden Infection Risk in RA Medications: What a Massive Study Reveals About Biologic Drug Safety
A comprehensive analysis of infection risks comparing abatacept and TNF inhibitors in rheumatoid arthritis patients based on a nationwide cohort study.
The Treatment Dilemma: When Can RA Patients Safely Stop Advanced Therapies?
Exploring the evidence on discontinuing advanced therapies for rheumatoid arthritis patients in remission, including risks, success factors, and clinical outcomes.
The Great Cholesterol Puzzle: How RA Treatments Reshape Your Lipid Profile
Exploring how different RA treatments affect cholesterol profiles and cardiovascular risk in rheumatoid arthritis patients.
Decoding RA's Blueprint: How Modern Drugs Are Revolutionizing Rheumatoid Arthritis Care
Explore how synthetic and biological DMARDs are transforming rheumatoid arthritis treatment according to the 2022 EULAR guidelines.
The Arthritis Revolution: How Targeted Therapies Are Changing the Game for Rheumatoid Patients
Comparative analysis of bDMARDs and tsDMARDs for rheumatoid arthritis treatment, including efficacy rankings and safety profiles.